Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-16 Sale | 2024-04-18 5:12 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $7.6636 | $87,725 | 7,229,861 (Direct) | View |
| 2024-04-16 Sale | 2024-04-18 5:12 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 48,124 | $7.6263 | $367,007 | 4,447,837 (Direct) | View |
| 2024-04-03 Sale | 2024-04-05 5:44 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 130,000 | $8.93 | $1,160,900 | 4,077,835 (Indirect Direct) | View |
| 2024-04-02 Sale | 2024-04-03 5:42 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $8.8182 | $100,942 | 7,241,308 (Direct) | View |
| 2024-03-28 Sale | 2024-04-01 6:40 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 65,000 | $10.1 | $656,500 | 4,232,835 (Indirect Direct) | View |
| 2024-03-21 Sale | 2024-03-25 6:39 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 8,000 | $10.75 | $85,980 | 2,324,031 (Direct) | View |
| 2024-03-19 Sale | 2024-03-21 5:38 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $10.79 | $216,423 | 7,252,755 (Direct) | View |
| 2024-03-12 Sale | 2024-03-14 7:28 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $10.74 | $537,190 | 4,570,961 (Direct) | View |
| 2024-03-06 Sale | 2024-03-08 7:08 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 61,319 | $11.73 | $719,505 | 10,784,331 (Indirect Direct) | View |
| 2024-03-05 Sale | 2024-03-07 6:53 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $12.06 | $241,805 | 7,272,809 (Direct) | View |
| 2024-02-22 Sale | 2024-02-23 7:22 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 8,000 | $14.89 | $119,160 | 2,332,031 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 5:37 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $12.32 | $247,125 | 7,292,863 (Direct) | View |
| 2024-02-13 Sale | 2024-02-15 6:00 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $10.16 | $507,985 | 4,703,133 (Direct) | View |
| 2024-02-07 Sale | 2024-02-09 5:34 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 48,272 | $9.2182 | $444,981 | 9,858,536 (Indirect Direct) | View |
| 2024-02-06 Sale | 2024-02-08 6:54 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $9.3028 | $106,489 | 7,312,917 (Direct) | View |
| 2024-01-25 Sale | 2024-01-29 6:52 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 8,000 | $10.35 | $82,762 | 1,666,680 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 6:13 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $10.58 | $212,083 | 7,324,364 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 6:39 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $10.93 | $196,740 | 796,610 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 6:37 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $10.35 | $517,508 | 4,299,416 (Direct) | View |
| 2024-01-09 Sale | 2024-01-11 6:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 29,000 | $13.66 | $396,214 | 3,170,666 (Indirect Direct) | View |
| 2024-01-09 Sale | 2024-01-11 6:50 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $13.62 | $273,202 | 7,344,418 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 8:03 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 55,853 | $9.4994 | $530,567 | 9,916,808 (Indirect Direct) | View |
| 2023-12-28 Sale | 2024-01-02 4:58 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 8,000 | $10.58 | $84,654 | 1,674,680 (Direct) | View |
| 2023-12-26 Sale | 2023-12-28 5:48 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $10.63 | $213,144 | 7,364,472 (Direct) | View |
| 2023-12-15 Sale | 2023-12-19 7:22 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $9.6 | $172,800 | 814,610 (Direct) | View |
| 2023-12-14 Sale | 2023-12-18 6:44 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director | 20,141 | $9 | $181,269 | 53,823 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-16 Exercise | 2024-04-18 5:12 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,447,837 (Direct) | View |
| 2024-04-16 Exercise | 2024-04-18 5:12 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,447,837 (Direct) | View |
| 2024-04-03 Gift | 2024-04-05 5:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,077,835 (Direct) | View |
| 2024-04-03 Conversion | 2024-04-05 5:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 50,000 | $0 | 4,077,835 (Indirect) | View |
| 2024-04-01 Option Award | 2024-04-03 5:43 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 1,267 | $0 | 3,171,933 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 5:43 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director | 2,001 | $0 | 60,078 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 5:43 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director | 1,467 | $0 | 89,056 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 5:42 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director | 1,467 | $0 | 56,314 (Direct) | View |
| 2024-03-28 Gift | 2024-04-01 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,232,835 (Direct) | View |
| 2024-03-28 Exercise | 2024-04-01 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,232,835 (Indirect) | View |
| 2024-03-28 Conversion | 2024-04-01 6:40 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 25,000 | $0 | 4,232,835 (Indirect) | View |
| 2024-03-21 Exercise | 2024-03-25 6:39 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 8,000 | $0 | 2,324,031 (Direct) | View |
| 2024-03-21 Exercise | 2024-03-25 6:39 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 8,000 | $1.06 | 2,324,031 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 7:28 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,570,961 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 7:28 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,570,961 (Direct) | View |
| 2024-03-06 Gift | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 10,784,331 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 8,674 | $11.4 | 10,784,331 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 7:08 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 39,924 | $0 | 10,784,331 (Direct) | View |
| 2024-03-06 Conversion | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 35,000 | $0 | 10,784,331 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 7:08 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 10,784,331 (Direct) | View |
| 2024-02-22 Exercise | 2024-02-23 7:22 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 8,000 | $0 | 2,332,031 (Direct) | View |
| 2024-02-22 Exercise | 2024-02-23 7:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 8,000 | $1.06 | 2,332,031 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 7:59 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 7,172 | $12.43 | 1,179,179 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 7:58 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 5,379 | $12.43 | 639,982 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 7:57 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 11,148 | $12.43 | 1,104,919 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 6:00 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,703,133 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 6:00 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,703,133 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 7:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Mauro David J Chief Medical Officer | 1,892 | $10.09 | 725,592 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 7:03 pm | N/A 2034-02-09 | RECURSION PHARMACEUTICALS INC. | RXRX | Mauro David J Chief Medical Officer | 155,345 | $0 | 725,592 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 7:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 2,512 | $10.09 | 3,755,498 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 7:01 pm | N/A 2034-02-09 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 531,229 | $0 | 3,755,498 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 7:00 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 2,800 | $10.09 | 2,345,410 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 7:00 pm | N/A 2034-02-09 | RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO | 681,530 | $0 | 2,345,410 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 6:55 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 3,233 | $10.09 | 10,866,798 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 6:55 pm | N/A 2034-02-09 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 1,011,495 | $0 | 10,866,798 (Direct) | View |
| 2024-02-07 Gift | 2024-02-09 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,858,536 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:34 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,858,536 (Direct) | View |
| 2024-02-07 Conversion | 2024-02-09 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,858,536 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,858,536 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 6:52 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 8,000 | $0 | 1,666,680 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 6:52 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 8,000 | $1.06 | 1,666,680 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 6:39 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $0 | 796,610 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 6:39 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $2.22 | 796,610 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 6:37 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,299,416 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 6:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,299,416 (Direct) | View |
| 2024-01-03 Gift | 2024-01-05 8:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 10,000 | $0 | 9,916,808 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-05 8:03 pm | N/A 2030-12-30 | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $0 | 9,916,808 (Direct) | View |
| 2024-01-03 Conversion | 2024-01-05 8:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 35,000 | $0 | 9,916,808 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-05 8:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 31,250 | $2.48 | 9,916,808 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 6:11 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director | 1,900 | $0 | 58,077 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 6:11 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director | 1,393 | $0 | 55,216 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 6:11 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 1,203 | $0 | 3,199,666 (Direct) | View |
| 2023-12-28 Exercise | 2024-01-02 4:58 pm | N/A 2028-07-22 | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 8,000 | $0 | 1,674,680 (Direct) | View |
| 2023-12-28 Exercise | 2024-01-02 4:58 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO | 8,000 | $1.06 | 1,674,680 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-19 7:22 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $0 | 814,610 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-19 7:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer | 18,000 | $2.22 | 814,610 (Direct) | View |